A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis

Yuta Norimatsu; Yurie Norimatsu

doi:10.1016/j.mmcr.2022.03.001

A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis

Med Mycol Case Rep. 2022 Mar 12:36:19-22. doi: 10.1016/j.mmcr.2022.03.001. eCollection 2022 Jun.

Authors

Yuta Norimatsu^{1

2}, Yurie Norimatsu²

Affiliations

¹ Department of Dermatology, University of Tokyo Graduate School of Medicine, 113-8655, 7-3-1,Hongo, Bunkyo-ku, Tokyo, Japan.
² Department of Dermatology, Ageo Daiichi Clinic for Internal Medicine and Pediatrics, 362-0064, 845-1 Koshikidani, Ageo, Saitama, Japan.

Abstract

We present a case of deep dermatomycosis caused by Trichophyton rubrum that developed after administration of SARS-CoV-2 BNT162b2 vaccination. A 75-year-old man was vaccinated with SARS-CoV-2 on day 0 and day 23. From day 25, pustules began to appear. A skin biopsy was performed. Tissue culture revealed the presence of Trichophyton rubrum. The patient was treated with topical luliconazole and 100 mg/day oral fosravuconazole for 84 days, after which the symptoms resolved.

Keywords: BNT162b2; Fosravuconazole; Pustular psoriasis; SARS-CoV-2 vaccination; Trichophyton rubrum; dermatomycosis.

Publication types

Case Reports